News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
5,849 Results
Type
Article (573)
Company Profile (2)
Press Release (5274)
Section
Business (1103)
Career Advice (6)
Deals (227)
Drug Development (536)
Employer Resources (1)
FDA (544)
Job Trends (104)
News (2505)
Policy (225)
Tag
Academia (30)
Alliances (259)
Alzheimer's disease (12)
Approvals (546)
Artificial intelligence (5)
Bankruptcy (1)
Best Places to Work (83)
Brain cancer (1)
Breast cancer (3)
Cancer (7)
Cardiovascular disease (8)
Career advice (6)
Clinical research (488)
Collaboration (4)
Compensation (3)
Complete response letters (1)
COVID-19 (9)
C-suite (3)
Data (30)
Diabetes (1)
Diagnostics (21)
Duchenne muscular dystrophy (1)
Earnings (418)
Employer resources (1)
Events (647)
Executive appointments (6)
FDA (578)
Funding (10)
Gene therapy (4)
GLP-1 (2)
Government (29)
Guidances (3)
Healthcare (100)
Huntington's disease (2)
Infectious disease (10)
Inflammatory bowel disease (1)
Intellectual property (2)
Interviews (4)
IPO (60)
Job creations (23)
Job search strategy (3)
Labor market (1)
Layoffs (1)
Legal (30)
Liver cancer (1)
Longevity (1)
Management (1)
Manufacturing (1)
Medical device (269)
Medtech (269)
Mergers & acquisitions (174)
Metabolic disorders (12)
Multiple sclerosis (2)
Neuroscience (30)
NextGen: Class of 2025 (43)
Non-profit (22)
Obesity (10)
Parkinson's disease (5)
Patents (7)
People (388)
Pharmaceutical (1)
Phase I (90)
Phase II (192)
Phase III (210)
Pipeline (18)
Postmarket research (53)
Preclinical (40)
Rare diseases (3)
Real estate (24)
Regulatory (201)
Research institute (19)
RNA editing (1)
Schizophrenia (7)
Series A (1)
Series B (3)
Sponsored (1)
Startups (20)
Vaccines (2)
Venture capital (1)
Date
Last 7 days (3)
Last 30 days (25)
Last 365 days (267)
2025 (166)
2024 (293)
2023 (299)
2022 (375)
2021 (394)
2020 (332)
2019 (377)
2018 (286)
2017 (312)
2016 (319)
2015 (374)
2014 (282)
2013 (249)
2012 (265)
2011 (289)
2010 (275)
Location
Africa (1)
Arizona (3)
Asia (138)
Australia (17)
California (62)
Canada (30)
China (1)
Colorado (6)
Connecticut (13)
Delaware (2)
Europe (793)
Florida (3)
Georgia (2)
Illinois (14)
Japan (3)
Kansas (1)
Maine (5)
Maryland (8)
Massachusetts (73)
Minnesota (2)
Missouri (1)
Nevada (4)
New Jersey (17)
New York (5)
North Carolina (31)
Northern California (20)
Ohio (1)
Pennsylvania (23)
South America (6)
South Carolina (8)
Southern California (32)
Tennessee (1)
Texas (6)
United States (286)
Utah (2)
Washington State (1)
5,849 Results for "rhythm".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Obesity
Rhythm Drug Leads to Reduced BMI in Rare Obesity Indication
Stifel analysts were bullish on the data, which showed a 16.5% drop in body-mass index among patients with damage to the hypothalamus taking Rhythm Pharmaceuticals’ Imcivree.
April 7, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
July 10, 2025
·
3 min read
Press Releases
Rhythm Pharmaceuticals, Inc. Announces Pricing of Upsized Public Offering of Common Stock
July 10, 2025
·
3 min read
Press Releases
Rhythm Pharmaceuticals to Report Second Quarter 2025 Financial Results on Tuesday, August 5, 2025
July 23, 2025
·
6 min read
Press Releases
Rhythm Pharmaceuticals Presents Data on MC4R Agonists Setmelanotide and Bivamelagon at ENDO 2025
July 14, 2025
·
12 min read
Press Releases
Rhythm Pharmaceuticals Announces Three Late-breaking Data Abstracts Accepted for Presentation at ENDO 2025
June 25, 2025
·
8 min read
Press Releases
CardioFocus to Showcase PFA Portfolio at Heart Rhythm 2025
April 23, 2025
·
2 min read
Press Releases
Rhythm Pharmaceuticals To Announce Topline Results from Phase 2 Trial Evaluating Oral MC4R Agonist Bivamelagon in Acquired Hypothalamic Obesity
July 8, 2025
·
7 min read
Press Releases
Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences - May 6, 2025
May 7, 2025
·
7 min read
Press Releases
Rhythm Pharmaceuticals Reports First Quarter 2025 Financial Results and Business Update
May 7, 2025
·
20 min read
1 of 585
Next
